Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iodixanol in MDCT-CA
NCT00209404Phase 4Completed
- Sponsor
- GE HealthCare
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of iodixanol in coronary artery disease (CAD), sponsored by GE HealthCare. Started Jul 2005; status: completed.
02
Drugs
iodixanol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00209404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00209404.